NF-kappa B and Oct-2 synergize to activate the human 3' Igh hs4 enhancer in B cells
In B cells, the Igh gene locus contains several DNase I-hypersensitive (hs) sites with enhancer activity. These include the 3' Igh enhancers, which are located downstream of the Calpha gene(s) in both mouse and human. In vivo experiments have implicated murine 3' enhancers, hs3B and/or hs4...
Gespeichert in:
| Veröffentlicht in: | The Journal of immunology (1950) Jg. 172; H. 2; S. 1054 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
15.01.2004
|
| Schlagworte: | |
| ISSN: | 0022-1767 |
| Online-Zugang: | Weitere Angaben |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | In B cells, the Igh gene locus contains several DNase I-hypersensitive (hs) sites with enhancer activity. These include the 3' Igh enhancers, which are located downstream of the Calpha gene(s) in both mouse and human. In vivo experiments have implicated murine 3' enhancers, hs3B and/or hs4, in class switching and somatic hypermutation. We previously reported that murine hs4 was regulated by NF-kappaB, octamer binding proteins, and Pax5 (B cell-specific activator protein). In this study we report that human hs4 is regulated differently. EMSAs and Western analysis of normal B cells before and after stimulation with anti-IgM plus anti-CD40 showed the same complex binding pattern formed by NF-kappaB, Oct-1, and Oct-2 (but not by Pax5). A similar EMSA pattern was detected in mature human B cell lines (BL-2, Ramos, and HS-Sultan) and in diffuse large B cell lymphoma cell lines, although yin yang 1 protein (YY1) binding was also observed. We have confirmed the in vivo association of these transcription factors with hs4 in B cells by chromatin immunoprecipitation assays. The diffuse large B cell lymphoma cell lines had a distinctive slow-migrating complex containing YY1 associated with Rel-B. We have confirmed by endogenous coimmunoprecipitation an association of YY1 with Rel-B, but not with other NF-kappaB family members. Transient transfection assays showed robust hs4 enhancer activity in the mature B cell lines, which was dependent on synergistic interactions between NF-kappaB and octamer binding proteins. In addition, human hs4 enhancer activity required Oct-2 and correlated with expression of Oct coactivator from B cells (OCA-B). |
|---|---|
| AbstractList | In B cells, the Igh gene locus contains several DNase I-hypersensitive (hs) sites with enhancer activity. These include the 3' Igh enhancers, which are located downstream of the Calpha gene(s) in both mouse and human. In vivo experiments have implicated murine 3' enhancers, hs3B and/or hs4, in class switching and somatic hypermutation. We previously reported that murine hs4 was regulated by NF-kappaB, octamer binding proteins, and Pax5 (B cell-specific activator protein). In this study we report that human hs4 is regulated differently. EMSAs and Western analysis of normal B cells before and after stimulation with anti-IgM plus anti-CD40 showed the same complex binding pattern formed by NF-kappaB, Oct-1, and Oct-2 (but not by Pax5). A similar EMSA pattern was detected in mature human B cell lines (BL-2, Ramos, and HS-Sultan) and in diffuse large B cell lymphoma cell lines, although yin yang 1 protein (YY1) binding was also observed. We have confirmed the in vivo association of these transcription factors with hs4 in B cells by chromatin immunoprecipitation assays. The diffuse large B cell lymphoma cell lines had a distinctive slow-migrating complex containing YY1 associated with Rel-B. We have confirmed by endogenous coimmunoprecipitation an association of YY1 with Rel-B, but not with other NF-kappaB family members. Transient transfection assays showed robust hs4 enhancer activity in the mature B cell lines, which was dependent on synergistic interactions between NF-kappaB and octamer binding proteins. In addition, human hs4 enhancer activity required Oct-2 and correlated with expression of Oct coactivator from B cells (OCA-B). In B cells, the Igh gene locus contains several DNase I-hypersensitive (hs) sites with enhancer activity. These include the 3' Igh enhancers, which are located downstream of the Calpha gene(s) in both mouse and human. In vivo experiments have implicated murine 3' enhancers, hs3B and/or hs4, in class switching and somatic hypermutation. We previously reported that murine hs4 was regulated by NF-kappaB, octamer binding proteins, and Pax5 (B cell-specific activator protein). In this study we report that human hs4 is regulated differently. EMSAs and Western analysis of normal B cells before and after stimulation with anti-IgM plus anti-CD40 showed the same complex binding pattern formed by NF-kappaB, Oct-1, and Oct-2 (but not by Pax5). A similar EMSA pattern was detected in mature human B cell lines (BL-2, Ramos, and HS-Sultan) and in diffuse large B cell lymphoma cell lines, although yin yang 1 protein (YY1) binding was also observed. We have confirmed the in vivo association of these transcription factors with hs4 in B cells by chromatin immunoprecipitation assays. The diffuse large B cell lymphoma cell lines had a distinctive slow-migrating complex containing YY1 associated with Rel-B. We have confirmed by endogenous coimmunoprecipitation an association of YY1 with Rel-B, but not with other NF-kappaB family members. Transient transfection assays showed robust hs4 enhancer activity in the mature B cell lines, which was dependent on synergistic interactions between NF-kappaB and octamer binding proteins. In addition, human hs4 enhancer activity required Oct-2 and correlated with expression of Oct coactivator from B cells (OCA-B).In B cells, the Igh gene locus contains several DNase I-hypersensitive (hs) sites with enhancer activity. These include the 3' Igh enhancers, which are located downstream of the Calpha gene(s) in both mouse and human. In vivo experiments have implicated murine 3' enhancers, hs3B and/or hs4, in class switching and somatic hypermutation. We previously reported that murine hs4 was regulated by NF-kappaB, octamer binding proteins, and Pax5 (B cell-specific activator protein). In this study we report that human hs4 is regulated differently. EMSAs and Western analysis of normal B cells before and after stimulation with anti-IgM plus anti-CD40 showed the same complex binding pattern formed by NF-kappaB, Oct-1, and Oct-2 (but not by Pax5). A similar EMSA pattern was detected in mature human B cell lines (BL-2, Ramos, and HS-Sultan) and in diffuse large B cell lymphoma cell lines, although yin yang 1 protein (YY1) binding was also observed. We have confirmed the in vivo association of these transcription factors with hs4 in B cells by chromatin immunoprecipitation assays. The diffuse large B cell lymphoma cell lines had a distinctive slow-migrating complex containing YY1 associated with Rel-B. We have confirmed by endogenous coimmunoprecipitation an association of YY1 with Rel-B, but not with other NF-kappaB family members. Transient transfection assays showed robust hs4 enhancer activity in the mature B cell lines, which was dependent on synergistic interactions between NF-kappaB and octamer binding proteins. In addition, human hs4 enhancer activity required Oct-2 and correlated with expression of Oct coactivator from B cells (OCA-B). |
| Author | Birshtein, Barbara K Sepulveda, Manuel A Emelyanov, Alexander V |
| Author_xml | – sequence: 1 givenname: Manuel A surname: Sepulveda fullname: Sepulveda, Manuel A organization: Department of Cell Biology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA – sequence: 2 givenname: Alexander V surname: Emelyanov fullname: Emelyanov, Alexander V – sequence: 3 givenname: Barbara K surname: Birshtein fullname: Birshtein, Barbara K |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/14707079$$D View this record in MEDLINE/PubMed |
| BookMark | eNo1kE9Pg0AUxPdQY__oJzAxe9IT-HZZ2OWojdUmjT2oZ_KAR6HCUlkwqZ9ejDVzmDn8MpnMnE1sa4mxKwG-AhXf7aumGWxb-0JLX_oCQjVhMwApPaEjPWVz5_YAEIFU52wqlIZR8Yy9vqy8DzwckD9wtDnfZr0nuTta6nbVN_G-5Zj11Rf2Yy6Jl0ODlge3fL0reekUJ1uizajjlR0rMqprd8HOCqwdXZ58wd5Xj2_LZ2-zfVov7zdeFmjde1EYxyoio5VAUQQgshQipSOZymwcZ_JYkghzaXSgSBksCtSpRgxNQWlEJBfs5q_30LWfA7k-aSr3uwAttYNLDIAJgwBG8PoEDmlDeXLoqga7Y_J_g_wBSfZeTw |
| CitedBy_id | crossref_primary_10_3389_fimmu_2023_996119 crossref_primary_10_1128_MCB_01176_13 crossref_primary_10_1016_j_drup_2019_04_001 crossref_primary_10_1016_j_ejphar_2006_07_012 crossref_primary_10_3390_cancers13235949 crossref_primary_10_1016_j_gene_2004_10_009 crossref_primary_10_1128_MCB_25_4_1511_1525_2005 crossref_primary_10_1016_j_ajhg_2015_06_010 crossref_primary_10_1016_j_heliyon_2024_e24376 crossref_primary_10_1016_j_molcel_2024_01_007 crossref_primary_10_1074_jbc_M407496200 crossref_primary_10_1517_14728222_10_2_253 crossref_primary_10_1093_toxsci_kfq324 crossref_primary_10_1136_ard_2010_147025 crossref_primary_10_2217_epi_2016_0147 crossref_primary_10_1038_sj_onc_1209127 crossref_primary_10_1128_MCB_02020_06 crossref_primary_10_1016_j_immuni_2024_05_006 crossref_primary_10_3389_fimmu_2014_00163 crossref_primary_10_4049_jimmunol_1101111 crossref_primary_10_1038_sj_onc_1209080 crossref_primary_10_3390_cancers15174338 crossref_primary_10_1038_s41389_019_0146_y crossref_primary_10_1007_s00726_006_0482_z crossref_primary_10_1089_vim_2019_0144 crossref_primary_10_1074_jbc_M111_243543 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.4049/jimmunol.172.2.1054 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine Biology |
| ExternalDocumentID | 14707079 |
| Genre | Research Support, U.S. Gov't, P.H.S Journal Article |
| GrantInformation_xml | – fundername: NIAID NIH HHS grantid: AI 13509 – fundername: NIAID NIH HHS grantid: AI 41572 – fundername: NCI NIH HHS grantid: P30 CA 1330 |
| GroupedDBID | --- -~X .55 .GJ 18M 2WC 34G 39C 3O- 53G 5GY 5RE 5VS 5WD 79B 85S AARDX ABCQX ABDFA ABDPE ABEFU ABGNP ABJNI ABOCM ABPPZ ACGFO ACGFS ACIWK ACNCT ACPRK ADBBV ADIPN ADNWM AENEX AFFNX AFHIN AFOSN AFRAH AHMMS AHWXS AI. AIZAD ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CGR CUY CVF D0L DIK DU5 E3Z EBS ECM EIF EJD F5P FRP GX1 IH2 J5H K-O KQ8 L7B MVM NEJ NPM OCZFY OK1 OWPYF P0W P2P PQQKQ R.V RHF RHI ROX RZQ SJN SKT TR2 TWZ VH1 VXZ W8F WH7 WOQ X7M XJT XSW XTH YCJ YHG YIN ZE2 ZGI ZXP 0R~ 7X8 ABEJV ABXVV ADXHL AETEA ARBBW BCRHZ KOP |
| ID | FETCH-LOGICAL-c377t-659946e8741a1f301cb064762b2c7078d92e15d28734e48affa7b7aa58feb6ee2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 36 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000188005200038&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0022-1767 |
| IngestDate | Sun Nov 09 13:29:57 EST 2025 Wed Feb 19 02:32:52 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c377t-659946e8741a1f301cb064762b2c7078d92e15d28734e48affa7b7aa58feb6ee2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://journals.aai.org/jimmunol/article-pdf/172/2/1054/1177086/1054.pdf |
| PMID | 14707079 |
| PQID | 80085330 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_80085330 pubmed_primary_14707079 |
| PublicationCentury | 2000 |
| PublicationDate | 2004-01-15 |
| PublicationDateYYYYMMDD | 2004-01-15 |
| PublicationDate_xml | – month: 01 year: 2004 text: 2004-01-15 day: 15 |
| PublicationDecade | 2000 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | The Journal of immunology (1950) |
| PublicationTitleAlternate | J Immunol |
| PublicationYear | 2004 |
| SSID | ssj0006024 |
| Score | 1.92816 |
| Snippet | In B cells, the Igh gene locus contains several DNase I-hypersensitive (hs) sites with enhancer activity. These include the 3' Igh enhancers, which are located... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 1054 |
| SubjectTerms | 3' Untranslated Regions - immunology Animals B-Lymphocytes - chemistry B-Lymphocytes - immunology B-Lymphocytes - metabolism Chromatin - metabolism DNA-Binding Proteins - metabolism DNA-Binding Proteins - physiology Electrophoretic Mobility Shift Assay Enhancer Elements, Genetic - immunology Host Cell Factor C1 Humans Immunoglobulin Heavy Chains - genetics Immunoglobulin Heavy Chains - metabolism Mice NF-kappa B - metabolism NF-kappa B - physiology Nuclear Proteins Octamer Transcription Factor-1 Octamer Transcription Factor-2 PAX5 Transcription Factor Precipitin Tests Protein Binding - genetics Protein Binding - immunology Proteins - isolation & purification Proteins - metabolism Proto-Oncogene Proteins - isolation & purification Trans-Activators - metabolism Trans-Activators - physiology Transcription Factor RelB Transcription Factors - isolation & purification Transcription Factors - metabolism Transcription Factors - physiology Transfection |
| Title | NF-kappa B and Oct-2 synergize to activate the human 3' Igh hs4 enhancer in B cells |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/14707079 https://www.proquest.com/docview/80085330 |
| Volume | 172 |
| WOSCitedRecordID | wos000188005200038&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEB6qVfHio77qcw-Cp7VNsskmIIiKRcHWgg96K5vNxlYliU0s1F_vbB54Eg9eckuYHWZnvsnMNwNw7DtCWcqWVLC2oszgDhXCC6nFMFq5XHp23vL_fMd7PXcw8Po1OKu4MLqtsvKJuaMOYqn_kbdcDQ4w-T5PPqjeGaVrq-UCjTmoWwhktE3zwc-scKdtsmpWOMrAi5lDDCFx63WsyRfx-ymG71NT77plvyPMPNJ0Vv8n4xqslAiTXBQmsQ41FTVgsdg5OWvAUrespm_AQ69D30SSCHJJRBSQe5lRk6QzTQccfymSxUTTHqYIRwniRJLv8yPWCbl9GZFRyoiKRtpoJmQc4Sd0DSDdhKfO9ePVDS2XLFBpcZ5Rx_Y85igXkYUwQrzu0tf8U8f0TaknAQWeqQw7wMTKYoq5IgwF97kQthsq31HK3IL5KI7UDhB0Dnh8Jvyc2WCZAsGhL6UMLBUKZhtNOKrUNkQj1lKJSMWf6bBSXBO2C80Pk2LWBmYmPB_it_vnu3uwXHTVGNSw96Ee4vVVB7Agp9k4nRzmtoHPXr_7DUxbwHQ |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=NF-kappa+B+and+Oct-2+synergize+to+activate+the+human+3%27+Igh+hs4+enhancer+in+B+cells&rft.jtitle=The+Journal+of+immunology+%281950%29&rft.au=Sepulveda%2C+Manuel+A&rft.au=Emelyanov%2C+Alexander+V&rft.au=Birshtein%2C+Barbara+K&rft.date=2004-01-15&rft.issn=0022-1767&rft.volume=172&rft.issue=2&rft.spage=1054&rft_id=info:doi/10.4049%2Fjimmunol.172.2.1054&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1767&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1767&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1767&client=summon |